In combination with the above in vivo experiments, hBM-MSCs deduce the NADPH oxidase pathway, accompanied by the inhibitions of HSC activation and liver fibrosis in CCl4-induced liver injury of mice. This evidence concerns the gene FMO5 and Hepatic fibrosis.